Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oldenlandia umbellata is a small annual herb native to India, prized in Ayurveda and Siddha systems of medicine for its therapeutic benefits. Traditionally, the roots and leaves are used to treat bleeding conditions, ulcers, toxic bites, cough, asthma, bronchitis, and fever. The plant is also notable for producing a red dye from its roots due to anthraquinone derivatives. Pharmacological studies indicate its extracts possess anti-tussive, anti-inflammatory, antioxidant, hepatoprotective, and significant antibacterial properties. The active constituents include flavonoids, triterpenoids, alkaloids, tannins, and glycosides. Its expectorant, styptic, febrifuge, and antimicrobial effects arise from both direct phytochemical interactions and general bioactive properties, rather than action on specific molecular targets. Oldenlandia umbellata is used in the development of herbal medicines and is the subject of ongoing research aimed at validating its traditional applications and accelerating natural remedies against respiratory and infectious diseases[1][2][4][5][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oldenlandia umbellata.